Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QAME | ISIN: US92556V1061 | Ticker-Symbol: VIA
Tradegate
02.04.25
19:52 Uhr
7,984 Euro
-0,002
-0,02 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
S&P 500
1-Jahres-Chart
VIATRIS INC Chart 1 Jahr
5-Tage-Chart
VIATRIS INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,9687,98802.04.
7,9668,00602.04.
ACCESS Newswire
409 Leser
Artikel bewerten:
(2)

Viatris: Connecting People With Medicines, Around the World

Finanznachrichten News

By: Tim Goodenow

NORTHAMPTON, MA / ACCESSWIRE / June 6, 2024 / For many people, accessing the medicines they need is a matter of picking up a prescription at a pharmacy or hospital. But what many don't see is the intricate ecosystem that works to get the right medicine to them, at the right place, at the right time. Hundreds of extraordinary processes come together seamlessly to produce and deliver these medicines through the global pharmaceutical supply chain.

Many years before a patient picks up their medicine, the journey begins with drug discovery followed by research and development work as part of a closely-regulated process - intended to assure the public that approved medicines and medical devices work correctly and as intended.

To then bring an approved drug or device to patients, companies like Viatris undertake a rigorous process categorized in four steps: sourcing, manufacturing, distribution and delivery. Throughout each step of our operations, we are focused on producing, safeguarding and distributing our medicines in a safe, compliant and responsible manner along each crucial point of the supply chain.

Viatris operates a large internal network of manufacturing sites, along with many strategic partnerships to produce different medicines. This diverse network supports our ability to minimize disruption and enable supply continuity. Because no single country or company can meet the needs of all patients, the geographical range of our local, regional and global supply sites provide significant supply chain resiliency.

"At Viatris, access to medicine is fundamental to our mission and it begins with the ability to sustainably deliver high-quality medicines, to people around the world, regardless of geography or circumstance," says Peter McCormick, Chief Supply Officer at Viatris. "Our global and diverse supply chain allows us to be nimble and flexible to better serve the evolving needs of our customers and patients in countries across the globe. It is what enables us to supply medicines to approximately 1 billion patients worldwide every year."

Viatris was featured in the Healthier Together series, which goes behind the scenes to uncover the incredible efforts being made to create a healthier world for all. Check out our story on the importance of a global pharmaceutical supply chain for access to medicines.

Healthier Together is a video series, developed in consultation with the WHO Foundation and produced for organisations by BBC StoryWorks Commercial Productions.



View additional multimedia and more ESG storytelling from Viatris on 3blmedia.com.

Contact Info:
Spokesperson: Viatris
Website: https://www.3blmedia.com/profiles/viatris
Email: info@3blmedia.com

SOURCE: Viatris



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.